Liver Cancer clinical trials in Kansas

6 actively recruiting liver cancer trials at 4 sites across Kansas.

Data from ClinicalTrials.gov · last refreshed 2026-10-01

Phase 1, Phase 2 Recruiting Industry

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of ECT204, an investigational ARTEMIS® T-cell therapy, in adult subjects with GPC3-positive hepatocellular carcinoma (HCC) who …

Sponsor: Eureka Therapeutics Inc.

NCT ID: NCT04864054

Sites in Kansas:

Kansas University Medical Center, Principal Investigator: — Westwood, Kansas

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Academic/Other

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

The investigators propose to evaluate the safety of drug combinations in patients with advanced gastroesophageal cancer and other gastrointestinal (GI) malignancies. Finding effective novel therapies for patients with advanced gastric canc…

Sponsor: Anwaar Saeed

NCT ID: NCT03539822

Sites in Kansas:

University of Kansas Cancer Center — Westwood, Kansas

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers with FGF/FGFR pathway aberrations, including locally advanced/metastatic hepatocel…

Sponsor: Tyra Biosciences, Inc

NCT ID: NCT06915753

Sites in Kansas:

The University of Kansas Medical Center — Westwood, Kansas

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Kansas:

Saint Luke's Cancer Instititute - South — Overland Park, Kansas

View on ClinicalTrials.gov →

Recruiting Industry

DESTINY-PANTUMOUR04

This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have n…

Sponsor: AstraZeneca

NCT ID: NCT07124000

Sites in Kansas:

Research Site — Topeka, Kansas

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

This trial will provide the maximum tolerated dose for radiation therapy for liver tumors and describe the toxicity profile using the vGRID therapy technique. Based on trials using this type of radiation in other cancers demonstrating low …

Sponsor: University of Kansas Medical Center

NCT ID: NCT05727787

Sites in Kansas:

University of Kansas Medical Center — Kansas City, Kansas

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01